Overview

Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride
Criteria
Inclusion Criteria:

- Male or female outpatients with osteoarthritis knee pain.

Exclusion Criteria:

- Serious cardiovascular, hepatic, renal, respiratory, or hematologic illness, or other
medical or psychiatric condition that, in the opinion of the investigator, would
compromise participation or be likely to lead to hospitalization during the course of
the study.

- Previous exposure to duloxetine.